Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for allegedly making materially false statements and failing to disclose adverse information regarding its business and financial practices during the specified Class Period [1][3]. Group 1: Lawsuit Details - The lawsuit seeks to recover losses for investors who purchased Ardent Health securities between July 18, 2024, and November 12, 2025 [1]. - Investors have until March 9, 2026, to seek appointment as lead plaintiff in the class action [2]. Group 2: Allegations Against Ardent Health - The complaint alleges that Ardent Health and its executives misrepresented the company's reliance on historical collection reviews, which were claimed to be a primary source of information for determining collectability [4]. - In reality, the company allegedly used a 180-day threshold for accounts to become fully reserved, leading to inflated accounts receivable balances and delayed recognition of losses [5]. Group 3: Financial Impact - On November 12, 2025, Ardent Health disclosed a $43 million reduction in quarterly revenue and a $54 million increase in professional liability reserves, which were attributed to adverse prior-period claim developments [6]. - Following these disclosures, Ardent Health's stock price fell approximately 33%, from $14.05 to $9.30 per share, resulting in significant losses for investors [7].

New York, New York--(Newsfile Corp. - January 12, 2026) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class action lawsuit against Ardent Health, Inc. (NYSE: ARDT) and certain of the Company's senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws. If you invested in Ardent Health, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/ardent-heal ...

"刚入院时，妹妹还需要持续吸氧，现在可以做到脱离氧气设备自由呼吸了。"马明广介绍，此次治疗采 用"心肺一体化"综合诊疗模式，针对慢肺患儿常合并肺动脉高压、右心功能不全等特点，医疗团队不仅 聚焦肺部病变，更同步评估心脏负荷与功能状态，通过实时调控一氧化氮（iNO）吸入疗法、个体化氧 疗方案、营养支持及气道管理，实现心肺功能协同修复。护理团队全程提供24小时精细化照护，包括气 道湿化、呼吸功能训练、营养支持、中医康复和心理疏导等，保障治疗顺利推进。该院构建了"短期集 中干预+长期线上指导"相结合的跨境慢病管理体系，这对新加坡的慢肺兄妹在结束住院治疗回国后， 医疗团队将依托先进的远程医疗技术，通过线上平台为其提供系统、连贯的专业指导。 本报讯 去年12月30日，一对新加坡的兄妹因早产导致支气管肺发育不良（BPD）进入慢性阶段，在母 亲的带领下专门打"飞的"赴海口，到海南现代妇女儿童医院慢肺中心接受治疗。11日下午，3岁的哥哥 安安和1岁的妹妹萌萌，在该院慢肺中心顺利完成阶段性治疗，成功脱氧出院，并于12日上午启程返回 新加坡。 出院当日，患儿父母将一面写有"大爱无疆卫健康 医者心暖四方"的锦旗赠予海南现代妇女儿童医 ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Lianchi Hospital Group Co., Ltd. 蓮池醫院集團股份有限公司 (the "Company") (A joint stock company incorporated in the People's Republic of China with limited l ...

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - The lawsuit is filed in the U.S. District Court for the Middle District of Tennessee, captioned Postiwala v. Ardent Health, Inc., et al., No. 3:26-cv-00022 [3]. - Investors have until March 9, 2026, to request to be appointed to lead the case [3]. - The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Ardent Health securities [3]. Group 2: Allegations Against Ardent Health - Ardent Health operates acute care hospitals and healthcare facilities, with a critical focus on the collection of accounts receivable [4]. - The lawsuit alleges that Ardent Health misrepresented its process for determining the collectability of accounts receivable, claiming reliance on "detailed reviews of historical collections," while actually using a "180-day cliff" method [4]. - This misrepresentation allowed Ardent Health to report inflated accounts receivable and delay recognizing losses on uncollectable accounts, constituting a violation of federal securities laws [4]. Group 3: Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million decrease in revenue for the quarter and increased its professional liability reserves by $54 million due to adverse claim developments [5]. - Following this announcement, Ardent Health's stock price dropped by $4.75 per share, or over 33%, from $14.05 to $9.30 per share [5].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Company Overview - Ardent Health operates acute care hospitals and healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Misrepresentation - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method, leading to inflated accounts receivable figures [4]. Stock Price Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease and a $54 million increase in professional liability reserves, resulting in a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3]. Legal Representation - Bleichmar Fonti & Auld LLP, a leading law firm in securities class actions, is representing the plaintiffs, with a history of recovering significant amounts for investors [7].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. and its senior executives for securities fraud following a significant stock drop due to alleged violations of federal securities laws [1][3]. Company Overview - Ardent Health operates acute care hospitals and other healthcare facilities, with a focus on the collection of accounts receivable [4]. Allegations of Fraud - The lawsuit claims that Ardent Health misrepresented its process for determining the collectability of accounts receivable, stating it relied on "detailed reviews of historical collections," while in reality, it used a "180-day cliff" method that inflated reported accounts receivable and delayed loss recognition [4]. Stock Performance Impact - On November 12, 2025, Ardent Health announced a $43 million revenue decrease and a $54 million increase in professional liability reserves, leading to a stock price drop of $4.75 per share, or over 33%, from $14.05 to $9.30 [5]. Legal Proceedings - Investors have until March 9, 2026, to request to lead the case in the U.S. District Court for the Middle District of Tennessee, under the caption Postiwala v. Ardent Health, Inc., et al. [3].

Core Viewpoint - A class action lawsuit has been filed against Ardent Health, Inc. for allegedly misleading investors regarding its accounts receivable and financial reporting practices [1][2]. Group 1: Allegations - Ardent Health reportedly inflated its accounts receivable and delayed recognizing losses on uncollectable accounts during the class period [2]. - The company did not maintain sufficient professional malpractice liability insurance to cover claims arising from its operations [2]. - On November 12, 2025, Ardent Health disclosed a $43 million decrease in third quarter 2025 revenue due to revised assessments of accounts receivable collectability, leading to a significant stock price drop of nearly 34% [2]. Group 2: Legal Proceedings - Shareholders who purchased Ardent Health securities between July 18, 2025, and November 12, 2025, may be eligible to participate in the class action [1][3]. - Interested shareholders can contact Robbins LLP to serve as lead plaintiff, representing other class members in the litigation [3]. Group 3: Company Background - Robbins LLP is a recognized leader in shareholder rights litigation, focusing on helping shareholders recover losses and improve corporate governance since 2002 [4].

Core Viewpoint - Rosen Law Firm has announced a class action lawsuit against Ardent Health, Inc. for allegedly misleading investors about its business operations and accounts receivable practices during the period from July 18, 2024, to November 12, 2025 [1][2]. Allegations - The lawsuit claims that Ardent Health misrepresented its accounts receivable, stating that it employed an active monitoring process for collectability, which included detailed reviews of historical collections [3]. - Defendants allegedly downplayed the issue of increased claim denials by third-party payors, framing it as a slow payment issue rather than uncollectibility, and did not write off uncollectible accounts [3]. - Contrary to their claims, Ardent Health reportedly did not rely on detailed reviews for determining collectability and instead utilized a 180-day cliff for reserving accounts, allowing for inflated accounts receivable reporting [3]. - The company also allegedly lacked sufficient professional malpractice liability insurance to cover claims, particularly in the context of increasing social inflationary pressures in medical malpractice cases in New Mexico [3]. Next Steps - Shareholders interested in participating in the class action must file motions to serve as lead plaintiff by March 9, 2026, although participation is not required for recovery eligibility [4].

Core Viewpoint - The incident involving a patient at Nantong First People's Hospital has raised significant social concern, leading to an acknowledgment of medical negligence and a classification of the event as a level one medical accident, with the hospital bearing primary responsibility [1][2]. Group 1: Incident Details - The patient, Ms. Song, aged 60, initially visited the hospital for abdominal pain and later for heart palpitations, ultimately undergoing a cardiac procedure where complications led to her death [1]. - The medical accident investigation concluded that while the procedure had indications, there was inadequate risk communication and a failure to exercise due diligence during the operation, resulting in foreseeable but not entirely avoidable complications [1]. Group 2: Response and Future Actions - The hospital has expressed deep regret over the incident and is cooperating with investigations while accepting responsibility for the medical accident [1]. - Ongoing negotiations regarding civil compensation have stalled due to the family’s demands exceeding legal standards, but the hospital aims to resolve the matter amicably and improve medical safety management and service quality [2].